Shandong Sanyuan Biotechnology Co.,Ltd.
Shenzhen Stock ExchangeTotal Valuation
Shandong Sanyuan Biotechnology Co.,Ltd. carries a market capitalization of 4.80B, placing it among publicly traded companies globally.
| Market Cap | 4.80B |
| Enterprise Value | N/A |
Share Statistics
Shandong Sanyuan Biotechnology Co.,Ltd. currently has 202.33M shares outstanding.
| Shares Outstanding | 202.33M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Shandong Sanyuan Biotechnology Co.,Ltd. trades at a trailing price-to-earnings ratio of 54.12. The price-to-sales ratio is 9.15, and the price-to-book ratio stands at 7.82.
| PE Ratio | 54.12 |
| PS Ratio | 9.15 |
| PB Ratio | 7.82 |
| P/TBV Ratio | 1.40 |
| P/FCF Ratio | 37.00 |
| P/OCF Ratio | N/A |
Financial Position
Shandong Sanyuan Biotechnology Co.,Ltd. maintains a current ratio of 15.98, meaning it holds 16.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 15.98 |
| Quick Ratio | 4.44 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | 12.96 |
| Return on Assets (ROA) | 2.36 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 12.97 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 3.26 |
Taxes
Over the trailing twelve months, Shandong Sanyuan Biotechnology Co.,Ltd. has paid 28.54M in income taxes, reflecting an effective tax rate of 20.54.
| Income Tax | 28.54M |
| Effective Tax Rate | 20.54 |
Stock Price Statistics
Shandong Sanyuan Biotechnology Co.,Ltd.'s stock has declined approximately -23.91653% over the past 52 weeks. The 50-day moving average sits at 25.17, while the 200-day moving average is 26.81.
| Beta (5Y) | N/A |
| 52-Week Price Change | -23.91653% |
| 50-Day Moving Average | 25.17 |
| 200-Day Moving Average | 26.81 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Shandong Sanyuan Biotechnology Co.,Ltd. generated 654.02M in revenue and converted that into 110.52M in net income, yielding earnings per share of 0.53. EBITDA reached 42.00M, while operating income came in at 42.00M.
| Revenue | 654.02M |
| Gross Profit | 101.02M |
| Operating Income | 42.00M |
| Pretax Income | 138.94M |
| Net Income | 110.52M |
| EBITDA | 42.00M |
| EBIT | 42.00M |
| Earnings Per Share (EPS) | 0.53 |
Balance Sheet
Total book value stands at 765.00M, with working capital of 2.18B providing operational flexibility.
| Cash & Cash Equivalents | 645.58M |
| Total Debt | N/A |
| Net Debt | -251.88M |
| Equity (Book Value) | 765.00M |
| Book Value Per Share | 3.68 |
| Working Capital | 2.18B |
Cash Flow
After subtracting -161.68M in capital expenditures, free cash flow totaled -161.68M - equivalent to -0.78 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -161.68M |
| Free Cash Flow | -161.68M |
| FCF Per Share | -0.78 |
Margins
Shandong Sanyuan Biotechnology Co.,Ltd. operates with a gross margin of 15.45, reflecting its pricing power and cost economics. The operating margin of 6.42 and net profit margin of 16.90 provide insight into operational efficiency.
| Gross Margin | 15.45 |
| Operating Margin | 6.42 |
| Pretax Margin | 21.24 |
| Profit Margin | 16.90 |
| EBITDA Margin | 6.42 |
Dividends & Yields
The company's payout ratio of 245.64 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 1.30 |
| Dividend Yield | N/A |
| Payout Ratio | 245.64 |
| Shareholder Yield | 5.54 |
| FCF Yield | 2.70 |
Stock Splits
Shandong Sanyuan Biotechnology Co.,Ltd.'s most recent stock split took place on June 17, 2022 with a 2:3 split ratio.
| Last Split Date | 6/17/2022 |
| Split Ratio | 2:3 |
Scores
Shandong Sanyuan Biotechnology Co.,Ltd. posts an Altman Z-Score of 18.52, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 18.52 |